Sofinnova Investments as of Sept. 30, 2019
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 71 positions in its portfolio as reported in the September 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ascendis Pharma A S (ASND) | 9.7 | $107M | 1.1M | 96.32 | |
Natera (NTRA) | 9.2 | $102M | 3.1M | 32.80 | |
Amarin Corporation (AMRN) | 7.1 | $79M | 5.2M | 15.16 | |
Nextcure (NXTC) | 7.0 | $78M | 2.5M | 30.85 | |
Y Mabs Therapeutics (YMAB) | 5.0 | $55M | 2.1M | 26.06 | |
Spark Therapeutics | 4.2 | $47M | 481k | 96.98 | |
Principia Biopharma | 3.6 | $40M | 1.4M | 28.24 | |
Obseva Sa | 3.6 | $40M | 4.7M | 8.33 | |
Coherus Biosciences (CHRS) | 3.5 | $39M | 1.9M | 20.26 | |
Merus N V (MRUS) | 3.2 | $35M | 2.0M | 17.82 | |
Karuna Therapeutics Ord | 2.5 | $28M | 1.7M | 16.32 | |
Select Sector Spdr Tr option | 2.4 | $27M | 300k | 90.13 | |
Audentes Therapeutics | 2.4 | $26M | 934k | 28.09 | |
Bristol Myers Squibb (BMY) | 2.2 | $24M | 478k | 50.71 | |
Allergan | 2.0 | $23M | 134k | 168.29 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.9 | $21M | 122k | 169.41 | |
Amgen (AMGN) | 1.6 | $18M | 92k | 193.52 | |
Nucana Biomed ordinary shares | 1.6 | $17M | 2.4M | 7.24 | |
Neurocrine Biosciences (NBIX) | 1.6 | $17M | 192k | 90.12 | |
Nucana Plc american depositary shares (NCNA) | 1.5 | $16M | 2.3M | 7.24 | |
Acceleron Pharma | 1.5 | $16M | 408k | 39.51 | |
United Therapeutics Corporation (UTHR) | 1.4 | $16M | 194k | 79.76 | |
Pfizer (PFE) | 1.3 | $15M | 411k | 35.93 | |
Reata Pharmaceuticals Inc Cl A | 1.1 | $12M | 149k | 80.29 | |
Reata Pharmaceuticals Inc cl a | 1.1 | $12M | 149k | 80.29 | |
Iterum Therapeutics | 0.9 | $10M | 1.7M | 5.77 | |
Halozyme Therapeutics (HALO) | 0.9 | $9.9M | 636k | 15.51 | |
Tg Therapeutics (TGTX) | 0.9 | $9.7M | 1.7M | 5.62 | |
Ptc Therapeutics I (PTCT) | 0.9 | $9.7M | 287k | 33.82 | |
Chiasma | 0.7 | $8.1M | 1.6M | 4.95 | |
Sarepta Therapeutics (SRPT) | 0.7 | $8.0M | 106k | 75.33 | |
Kiniksa Pharmaceuticals (KNSA) | 0.7 | $7.9M | 923k | 8.51 | |
Macrogenics (MGNX) | 0.7 | $7.4M | 582k | 12.76 | |
Aimmune Therapeutics | 0.7 | $7.3M | 347k | 20.94 | |
Entasis Therapeutics Holdings Ord | 0.6 | $7.0M | 1.2M | 5.96 | |
Kadmon Hldgs | 0.6 | $6.6M | 2.6M | 2.52 | |
Dermira | 0.6 | $6.3M | 990k | 6.39 | |
Beigene Ltd call | 0.6 | $6.1M | 50k | 122.43 | |
Fate Therapeutics (FATE) | 0.5 | $5.9M | 382k | 15.53 | |
Myokardia | 0.5 | $5.9M | 114k | 52.15 | |
BioMarin Pharmaceutical (BMRN) | 0.5 | $5.7M | 85k | 67.40 | |
Amicus Therapeutics (FOLD) | 0.5 | $5.8M | 723k | 8.02 | |
Dicerna Pharmaceuticals | 0.5 | $4.9M | 343k | 14.36 | |
Akebia Therapeutics (AKBA) | 0.4 | $4.8M | 1.2M | 3.92 | |
Zymeworks | 0.4 | $4.7M | 188k | 24.79 | |
Heron Therapeutics (HRTX) | 0.4 | $4.2M | 227k | 18.51 | |
Xbiotech (XBIT) | 0.3 | $3.8M | 359k | 10.46 | |
Foamix Pharmaceuticals | 0.3 | $3.6M | 1.2M | 3.04 | |
Otonomy | 0.3 | $3.4M | 1.4M | 2.39 | |
Forty Seven | 0.3 | $3.3M | 519k | 6.42 | |
Orchard Therapeutics Plc ads | 0.3 | $3.4M | 283k | 11.89 | |
Calithera Biosciences | 0.3 | $3.0M | 965k | 3.09 | |
ArQule | 0.3 | $2.8M | 393k | 7.17 | |
Homology Medicines | 0.2 | $2.6M | 146k | 18.10 | |
Cytokinetics (CYTK) | 0.2 | $2.4M | 211k | 11.38 | |
Mirati Therapeutics | 0.2 | $2.4M | 31k | 77.88 | |
Aclaris Therapeutics (ACRS) | 0.2 | $2.1M | 1.9M | 1.08 | |
Align Technology (ALGN) | 0.2 | $1.8M | 10k | 180.97 | |
Syndax Pharmaceuticals (SNDX) | 0.2 | $1.8M | 243k | 7.47 | |
Kala Pharmaceuticals | 0.2 | $1.8M | 478k | 3.80 | |
Portola Pharmaceuticals | 0.1 | $1.6M | 59k | 26.83 | |
Syndax Pharmaceuticals | 0.1 | $1.5M | 200k | 7.47 | |
Applied Therapeutics (APLT) | 0.1 | $1.6M | 142k | 10.98 | |
BioCryst Pharmaceuticals (BCRX) | 0.1 | $1.5M | 517k | 2.86 | |
Savara (SVRA) | 0.1 | $1.4M | 527k | 2.65 | |
Synlogic | 0.1 | $1.3M | 575k | 2.29 | |
Apellis Pharmaceuticals (APLS) | 0.1 | $1.2M | 50k | 24.08 | |
Heron Therapeutics | 0.1 | $995k | 54k | 18.49 | |
Sunesis Pharmaceuticals Inc Ne | 0.1 | $816k | 1.1M | 0.72 | |
Syndax Pharmaceuticals Inc call | 0.1 | $746k | 100k | 7.46 | |
Pds Biotechnology Ord (PDSB) | 0.0 | $482k | 143k | 3.38 |